# OncoAudit Research Library
> Permanent Audit Trails of Global Oncology Drug Approvals.

| Year | Drug | Regulatory Bodies | Focus Area | Link |
| :--- | :--- | :--- | :--- | :--- |
| 2026 | **Rituximab** | FDA, MHLW, TFDA | Real-time Dosage Cycle Alignment | [View Case](./2026-01-rituximab-case.md) |
| 2025 | **Xeljanz** | EMA | Product Lifecycle Management | [View Case](./2025-xeljanz-ema-lifecycle.md) |
| 2013 | **Xeljanz** | TFDA | Local Regulatory Audit | [View Case](./2013-xeljanz-tfda-audit.md) |
| 2012 | **Rituxan** | FDA | Historical Label Comparison | [View Case](./2012-rituxan-fda-audit.md) |

---
**Methodology:** All data is parsed via OncoAudit's LLM engine and prepared for AO Permaweb sealing.
